2018 has been a tough year for JSE-listed pharmacy group Dis-Chem with the stock down 26% over the past 12 months.
The share is trading on a forward price to earnings multiple of around 30 times earnings and offers a less than compelling dividend yield of 1.19%.
Is there more to this stock?
Anchor Capital analyst, Henry Biddlecombe gives an investment insight into Dis-Chem:
[gravityform id=”2″ title=”true” description=”true”]